These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6449991)

  • 1. GABA and neuropsychiatric disorders.
    Enna SJ
    Can J Neurol Sci; 1980 Aug; 7(3):257-9. PubMed ID: 6449991
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurochemical and neuropharmacological indications for the involvement of GABA and glycine receptors in neuropsychiatric disorders.
    Lloyd KG; DeMontis G; Broekkamp CL; Thuret F; Worms P
    Adv Biochem Psychopharmacol; 1983; 37():137-48. PubMed ID: 6138947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Huntington chorea and neurotransmitters].
    Nakamura S
    Nihon Rinsho; 1984 Apr; 42(4):875-9. PubMed ID: 6237213
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain amino compounds in a Huntington's disease patient on isoniazid therapy.
    Perry TL; Wall RA; Hansen S
    Neurology; 1985 May; 35(5):755-8. PubMed ID: 3157886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemically specified subsystems in the basal ganglia.
    Graybiel AM
    Ciba Found Symp; 1984; 107():114-49. PubMed ID: 6149896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of GABA-immunoreactive neurons in the basal ganglia of the squirrel monkey (Saimiri sciureus).
    Smith Y; Parent A; Seguela P; Descarries L
    J Comp Neurol; 1987 May; 259(1):50-64. PubMed ID: 3294929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium-independent, high-affinity binding of [3H]gamma-aminobutyric acid in human neurological disorders.
    Lloyd KG; Dreksler S; Shemen L; Davidson L
    Adv Exp Med Biol; 1979; 123():399-418. PubMed ID: 160192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra gamma-aminobutyric acid receptors in Huntington's disease.
    Cross AJ; Waddington JL
    J Neurochem; 1981 Aug; 37(2):321-4. PubMed ID: 6267198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid peptides in Huntington's disease: alterations in prodynorphin and proenkephalin system.
    Seizinger BR; Liebisch DC; Kish SJ; Arendt RM; Hornykiewicz O; Herz A
    Brain Res; 1986 Jul; 378(2):405-8. PubMed ID: 2873872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The brain in Huntington's chorea.
    Bird ED
    Psychol Med; 1978 Aug; 8(3):357-60. PubMed ID: 151869
    [No Abstract]   [Full Text] [Related]  

  • 11. gamma-Aminobutyric acid receptors in normal human brain and Huntington disease.
    Van Ness PC; Watkins AE; Bergman MO; Tourtellotte WW; Olsen RW
    Neurology; 1982 Jan; 32(1):63-8. PubMed ID: 6275305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional distribution of gamma-aminobutyric acid (GABA) in brain of the rhesus monkey.
    Fahn S; Côté LJ
    J Neurochem; 1968 Mar; 15(3):209-13. PubMed ID: 4966292
    [No Abstract]   [Full Text] [Related]  

  • 13. [Topographical study on the distribution of gamma-aminobutyric acid (GABA) in the human substantia nigra].
    Kanazawa I
    Rinsho Shinkeigaku; 1975 Sep; 15(9):625-34. PubMed ID: 1239354
    [No Abstract]   [Full Text] [Related]  

  • 14. GABA content and glutamic acid decarboxylase activity in brain of Huntington's chorea patients and control subjects.
    Urquhart N; Perry TL; Hansen S; Kennedy J
    J Neurochem; 1975 May; 24(5):1071-5. PubMed ID: 124764
    [No Abstract]   [Full Text] [Related]  

  • 15. Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders.
    Chang L; Cloak CC; Ernst T
    J Clin Psychiatry; 2003; 64 Suppl 3():7-14. PubMed ID: 12662128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of extracellular GABA in the substantia nigra of the rat during seizures and anticonvulsant treatments.
    Sayin U; Timmerman W; Westerink BH
    Brain Res; 1995 Jan; 669(1):67-72. PubMed ID: 7712166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basal ganglia lesions and neurotransmitters].
    Yoshida M
    Nihon Rinsho; 1978; 36(1):58-64. PubMed ID: 24766
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurotransmitter receptors-biochemistry and alterations in nueropsychiatric disorders.
    Olsen RW; Reisine TD; Yamamura HI
    Life Sci; 1980 Sep; 27(10):801-8. PubMed ID: 6251327
    [No Abstract]   [Full Text] [Related]  

  • 19. GABA receptor binding and endogenous inhibitors in normal human brain and Huntington's disease.
    Olsen RW; Van Ness P; Napias C; Bergman M; Tourtellotte WW
    Adv Biochem Psychopharmacol; 1980; 21():451-60. PubMed ID: 6246754
    [No Abstract]   [Full Text] [Related]  

  • 20. GABA and benzodiazepine receptors in basal ganglia function.
    Young AB; Pan HS; Ciliax BJ; Penney JB
    Neurosci Lett; 1984 Jun; 47(3):361-7. PubMed ID: 6089057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.